New E-News Header 
In This Issue
News
Resources
Patient Education
Education
ASBP Quick Links

 

 

This e-newsletter is sponsored by 
Contact Us

American Society of

Bariatric Physicians

2821 S. Parker Road
Ste. 625

Aurora, CO 80014

303.770.2526 | asbp.org

 

Staff

Laurie Traetow, CAE

Executive Director

laurie@asbp.org   

 

Beth Amelon
Administrative Coordinator

beth@asbp.org 

 

Carly Crosby
Administrative Coordinator

carly@asbp.org

 

Peter Conway

Intern, Marketing & Communications
peter@asbp.org

 

Heidi Gordon

Director of Marketing &

Communications

heidi@asbp.org

 

Anna Hansen

Membership Manager 

anna@asbp.org   

 

Dana Mansell

CME Director &

Business Manager
dana@asbp.org

  

Stacy Schmidt, Ph.D.

Health Director
stacy@asbp.org

Obesity Medicine e-Weekly
News
BELVIQ obesity treatment medication available to U.S. patients beginning today 
Arena Pharmaceuticals, Inc.,announced that BELVIQ (lorcaserin HCl) CIV will be available to patients by prescription in U.S. pharmacies beginning TODAY (Tuesday, June 11). BELVIQ is a new medication approved by the U.S. Food & Drug Administration for use as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.Click here to read the complete news release.

 

Do you have an obesity medicine rotation?
As you are probably already aware, despite our nation being in the midst of an obesity crisis, obesity-specific education and training is still severely lacking in many medical schools and residency programs. In an effort to help students and residents learn more about obesity medicine, the ASBP Medical Students Outreach Task Force is compiling resources for medical students, including a list of physicians who currently offer clinical rotations for medical students and/or residents. If you are currently offering a clinical rotation, please send an e-mail to Administrative Coordinator Carly Crosby so that your name and practice information may be included on the list. 
 
Dr. Ethan Lazarus to represent the Society June 13-19 during AMA Annual Meeting of House of Delegates
Dr. Ethan Lazarus
Dr. Ethan Lazarus (Colorado) will serve as the official ASBP representative during the American Medical Association (AMA) Annual Meeting of the House of Delegates (HOD) this coming week in Chicago. Dr. Lazarus will also represent the Society at an ASBP information table, which will provide obesity medicine education and career materials for the Medical Student Section's 10th Annual Medical Specialty Showcase on June 15.
The Society is the only obesity medicine-specific national medical specialty society organization that holds a seat in the AMA HOD--a seat that the Society has held since 2001. Please click here for more information about this year's meeting, and look for a report from Dr. Lazarus in the coming weeks.
  
National Employee Wellness Month continues through June 30: Download free posters for your office
Now in its fifth year, National Employee Wellness Month helps employers focus on engaging employees in healthier lifestyles. This year, more than 175 companies--including the Society--have pledged support, joining sponsoring organizations Virgin HealthMiles, Strategies to Overcome and Prevent (STOP) Obesity Alliance, Partnership to Fight Chronic Disease and WorldatWork to demonstrate their commitment to promote healthy lifestyles and provide motivation and opportunities for employees to adopt healthy habits. In celebration of this effort, please click here to download PDF posters you can display in your office to encourage and inspire your employees or co-workers this month!

Resources

Obesity Updates: Click titles to view articles

Henry, R.R., et al. J. Diabetes Complications. May 2013.

Lifestyle changes (dietary modification focused on caloric reduction, increased physical activity, and behavior therapy) can produce weight loss in individuals affected by overweight and obesity. However, sustained adherence to these changes and maintenance of weight reduction is often challenging. This review article discusses treatment options for obesity, including the two compounds that were recently approved by the U.S. Food & Drug Administration: twice-daily lorcaserin (BELVIQ) and once-daily phentermine and extended-release topiramate (Qsymia).

    

Carbohydrate intake in the morning and reduced risk of metabolic syndrome
Almoosawi, S., et al. International Journal of Obesity. 2013.

Circadian rhythms control several physiological and metabolic processes in the human body, including glucose homeostasis and insulin secretion. There may be physiological windows of time when consumption of certain nutrients is favored over others. Short-term studies have shown that nutrient composition of meals can influence glucose, insulin and triglyceride responses; however, no epidemiological study has investigated the association between time of day and nutrient composition of eating occasions and the development of the metabolic syndrome. The present study analyzed 1,488 3-day diet records from the 1946 British Birth Cohort from individuals at age 43 years and for whom data on metabolic syndrome was available at age 53 years. They found that increasing energy intake from carbohydrate in the morning at the expense of fat was associated with lower triglycerides and lower likelihood of developing metabolic syndrome and abdominal obesity.

 

Cost effectiveness of primary care referral to a commercial weight loss program 

Fuller, N.R., et al. Int J Obesity. June 2013. 

A partnership between primary-care providers and commercial organizations may be a practical approach for patients to benefit from lifestyle intervention for weight management. This study evaluated the cost effectiveness of a commercial program (CP: Weight Watchers) compared with standard care (SC) for both weight loss and quality of life in Australia, the United Kingdom (UK) and Germany. Results show that both treatment groups lost weight, but mean 12-month weight loss was significantly greater for CP than SC; however, CP participants invested significantly more time, as they were required to visit with their group three times as often as SC. This resulted in significantly greater cost for CP, but the cost per kg of weight loss was $122, $90 and $180 for the CP in Australia, UK and Germany, respectively. For SC the cost was $138, $151 and $133, respectively. This indicates that it is cost effective for general practitioners to refer overweight and obese patients to a CP for weight loss. 

Advocacy 

June issue of Capitol Resource now available
CR_June2012_Cover
This month's issue of the Society's advocacy newsletter, Capitol Resource, is now available for download. Topics include:

  • Analysis of state Essential Health Benefits Benchmark plans show discriminatory benefit designs
  • Reps. Barletta and Schwartz urge U.S. Department of Health & Human Services to clarify if obesity is a chronic disease
  • Final rule on employer wellness programs
  • Update on Treat & Reduce Obesity Act

Education

Attend the Obesity Basic Medical Treatment course this Saturday in Rochester

The next of the summer Obesity Basic Medical Treatment courses is Saturday, June 15, in Rochester, N.Y. Attendees earn 7 hours of continuing medical education (CME), plus the second and subsequent registrations from the same office receive a $30 discount. The registration fee is $199, if received by the Wednesday prior to th course or $225 from Thursday to Saturday. The course, presented by the Obesity Medicine Association (a division of the Society), provides basic clinical information and tools to effectively treat patients affected by obesity and related conditions. Click here to learn more, or download a registration form and read details about the course. Online registration is also available for these dates and locations:  

- June 29 | Milwaukee, Wis. 

- July 13 | Virginia Beach, Va. 

- Aug. 3 | Providence, R.I.

  

Register today for the ASBP 63rd Annual Obesity & Associated Conditions Symposium 

SymposiumRegister online or click here to download a printable registration form for the ASBP 63rd Annual Obesity & Associated Conditions Symposium on Oct. 9-13, 2013, at the Arizona Biltmore in Phoenix. Click here to learn more about this year's conference, which includes up to 30 hours of continuing medical education (CME), an all-new course (Innovate 2013) and breakout tracks during the Obesity Course. If you are planning to take the American Board of Obesity Medicine certification exam, please remember that all CME may be counted in your 2013 application, including the Obesity Medicine Certification Review Course!
 
The American Society of Bariatric Physicians is a medical professional association for physicians, nurse practitioners and physician assistants who are focused on the treatment and management of patients affected by obesity and associated conditions and co-morbidities. The Society is the primary source for clinical education and training for the medical management of obesity.

Members of the Society are permitted and encouraged to share any of the content in this e-newsletter on their own blogs and websites, as appropriate.  

Advertising Disclaimer

Under a policy approved by the ASBP Executive Committee and Exhibitor/Advertiser Review Committee, commercial companies may apply to advertise in society publications. Approval does not imply ASBP's endorsement or official recognition of particular products and/or services. This policy also applies to books and products marketed on behalf of ASBP members.